Caxton Corporation Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$2.31M |
| 2 |
Alerian MLP ETF
AMLP
|
+$1.12M |
| 3 |
ELEV
Elevation Oncology
ELEV
|
+$5 |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$6.88M |
| 2 |
ACLX
Arcellx
ACLX
|
+$489K |
| 3 |
VECT
VectivBio Holding AG Ordinary Shares
VECT
|
+$292K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 61.8% |
| 2 | Miscellaneous | 38.2% |
Similar funds
Caxton Corporation's Q3 2022 Portfolio in Review
As of Q3 2022, Caxton Corporation held 18 positions worth $53.2M, down 29% from $74.4M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
Caxton Corporation withdrew a net $4.22M in Q3 2022, closing 1 position and reducing 3 holdings. Its most notable exit was SPDR Gold Trust, an estimated $6.88M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 44% a quarter earlier, followed by Miscellaneous.
Against the trend, Caxton Corporation opened a new position in State Street SPDR S&P Oil & Gas Exploration & Production ETF worth $2.18M.
- Caxton Corporation's largest Q3 2022 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 17,500 shares worth $2.18M.
- Caxton Corporation added most to Elevation Oncology in Q3 2022, an estimated $5 increase.
- Caxton Corporation's biggest Q3 2022 reduction was Arcellx, cutting an estimated $489K.
- Caxton Corporation fully exited SPDR Gold Trust in Q3 2022, selling an estimated $6.88M.
- Caxton Corporation's ten largest holdings make up 97% of its $53.2M portfolio in Q3 2022.
- Caxton Corporation opened 2 new positions and closed 1 in Q3 2022.
- Caxton Corporation's portfolio value fell 29% quarter-over-quarter to $53.2M.
Based on Caxton Corporation's 13F filing for Q3 2022, filed 14 Nov 2022.